BioSpace News Archive

Doug Doerfler, Chief Executive Officer, will present a company overview at the Piper Jaffray 30th Annual Healthcare Conference on Wednesday, November 28, 2018, at 1:10 p.m. ET in New York City.

Survey of 781 Medicare Advantage beneficiaries shows telehealth lags behind most desired covered services like home modification for medical needs, or food delivery services; plus, just 17 percent of respondents were aware their plan offered telehealth services

The presentation will take place at 8:10 a.m. ET on Tuesday, November 27, 2018.

Vieworks will demonstrate the latest technology and new products as well as offer a customized digital x-ray solution by consulting with visitors

On the heels of receiving four awards at FOLIO: in October, Experience Life, the whole-life health and fitness magazine, was awarded top honors in six categories on Thursday, November 1, at the Minnesota Media and Publishing Association (MMPA) Excellence Awards

BioTalent Canada announced the release of its fourth annual National Compensation Guide for Canada’s bio-economy today.

Following a career of nearly 40 years in health care leadership, Chuck Neumann, Principal of The Cambridge Group, Inc. and health system leader, announced that he will retire at the end of 2018.

Reliable Medical Supply (“RMS”) (www.reliamed.com), a healthcare Durable Medical Equipment (“DME”) company providing complex rehab therapy (“CRT”), clinical respiratory services, and an array of additional therapies treating a variety of disease states, announced today the recapitalization of their equity by Seven Hills Capital of Chicago.

Pulmatrix, Inc. (NASDAQ: PULM) announced the results of the completed first-in-human study of Pulmazole (PUR1900) — an inhaled iSPERSETM formulation of the anti-fungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in patients with asthma.

Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Chris Boshoff, senior vice president and head, Immuno-Oncology, Early Development and Translational Oncology, at the Evercore ISI HealthConX Conference on Wednesday, November 28, 2018 at 8:45 a.m. EST.